Chemical burns of the ocular surface

“Fortunately, the majority of chemical burns of the ocular surface are mild,” said Dr Harminder Dua MD, PhD at the EuCornea Congress.
But for the rest, prompt correct treatment can make a huge difference.
“Copious irrigation is a given, but make sure to use an eyelid speculum and, importantly, topical anaesthesia,” said Prof Dua.
Re-measuring the pH an hour or so after the end of irrigation is also crucial, since alkali can continue to ooze out of tissues, despite a normal pH immediately after irrigation.
Prof Dua said to avoid using 10 per cent phenylephrine, due to its vasoconstrictive effects, which can contribute to ischaemia. For intraocular pressure control, “substituting oral diamox for a topical agent removes at least one topical irritant from the treatment.”
Further, “alpha adrenergic agonists may not work, since collagen shrinkage affects uveosclera.
Tags: intraocular pressure, tissue types
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.